Citadel Advisors’s PolyPid PYPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-410
Closed -$8.58K 15345
2022
Q4
$8.58K Sell
410
-100
-20% -$2.58K ﹤0.01% 13741
2022
Q3
$18K Sell
510
-197
-28% -$24.4K ﹤0.01% 12112
2022
Q2
$98K Sell
707
-43
-6% -$6.43K ﹤0.01% 11430
2022
Q1
$123K Sell
750
-53
-7% -$8.03K ﹤0.01% 12066
2021
Q4
$138K Buy
+803
New +$170K ﹤0.01% 12375

Other funds holding PYPD

Citadel Advisors's PYPD Position: Q2 2026 in Review

Citadel Advisors reduced its PolyPid (PYPD) stake by 27% in Q2 2026, selling an estimated $71.4K and leaving 42,282 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #11906.

Citadel Advisors first reported a position in PYPD in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.65M in Q2 2020. 33 funds tracked by Wall St. Rank hold PYPD as of Q2 2026.

  • Citadel Advisors held 42,282 shares of PolyPid worth $215K as of Q2 2026.
  • Citadel Advisors sold 15,487 PolyPid shares in Q2 2026, an estimated $71.4K.
  • PolyPid made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11906 holding.
  • Citadel Advisors first reported a position in PolyPid in Q2 2020 and has held it in 12 quarters since.
  • Citadel Advisors's PolyPid position peaked at $1.65M in Q2 2020.
  • 33 funds tracked by Wall St. Rank held PolyPid as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.